Cancer Network presents exclusive coverage on ovarian cancer from the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, with reports on the latest clinical research changing
the way ovarian cancer patients are being managed and treated.
Not exact matches
In order to find out how and why
ovarian cancer cells grow and take on such lethal characteristics, Dr. Shepherd and his team grow the
cancer cells in 3D structures, called «spheroids» — the same
way the
cancer cells grow in
patients.
«If studies in larger groups of women confirm our finding that the fallopian tubes are the site of origin of most
ovarian cancer, then this could result in a major change in the
way we manage this disease for
patients at risk.»
Several phase I and II trials of adoptive T cell transfer techniques are currently under
way for
patients with
ovarian cancer, including:
Cancer Network: What are the ways to test for this deficiency of homologous recombination in patients with ovarian c
Cancer Network: What are the
ways to test for this deficiency of homologous recombination in
patients with
ovarian cancercancer?